NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

Rhea-AI Summary

NeuroOne Medical Technologies (Nasdaq: NMTC), a medical technology company focused on improving surgical care options for neurological disorders, has announced it will host a conference call and webcast on August 14, 2024, at 4:30 PM Eastern Time. The event will cover financial results for the third quarter of fiscal year 2024 ended June 30, 2024, and provide a corporate update.

The conference call will be accessible via toll-free and international numbers, with a participant access code. A phone replay will be available until August 28, 2024. Additionally, a live webcast will be provided, with the replay available for 12 months.

News Market Reaction

-3.71%

1 alert

-3.71% News Effect

On the day this news was published, NMTC declined 3.71%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

EDEN PRAIRIE, Minn., Aug. 12, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on August 14, 2024, at 4:30 PM Eastern Time to discuss financial results for its third quarter of fiscal year 2024 ended June 30, 2024, and provide a corporate update.

Conference Call and Webcast Information:

Wednesday, August 14, 2024 – 4:30 PM Eastern Time

Participants:
Toll Free: 877-545-0320
International: 973-528-0002
Participant Access Code: 579769

Phone Replay:
Toll Free: 877-481-4010
International: 919-882-2331
Replay Passcode: 51065
Available through August 28, 2024

Live Webcast: 
Join here.
Webcast replay available for 12 months

About NeuroOne

NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit nmtc1.com. 

Contact:
800-631-4030
ir@nmtc1.com

FAQ

When will NeuroOne (NMTC) report its Q3 FY2024 financial results?

NeuroOne (NMTC) will report its third quarter fiscal year 2024 financial results on August 14, 2024, during a conference call and webcast scheduled for 4:30 PM Eastern Time.

How can investors access NeuroOne's (NMTC) Q3 FY2024 earnings call?

Investors can access NeuroOne's (NMTC) Q3 FY2024 earnings call via phone (toll-free: 877-545-0320, international: 973-528-0002, access code: 579769) or through a live webcast. A replay will be available for both options.

What period does NeuroOne's (NMTC) upcoming financial report cover?

NeuroOne's (NMTC) upcoming financial report covers the third quarter of fiscal year 2024, which ended on June 30, 2024.

How long will the replay of NeuroOne's (NMTC) Q3 FY2024 earnings call be available?

The phone replay of NeuroOne's (NMTC) Q3 FY2024 earnings call will be available until August 28, 2024, while the webcast replay will be accessible for 12 months.